Complete clinical reference for the 2026 Surviving Sepsis Campaign international guidelines — 129 evidence-based recommendations covering screening, antimicrobial therapy, hemodynamic management, respiratory support, adjunctive therapies, goals of care, transitions, and long-term outcomes in adult sepsis and septic shock.
Surviving Sepsis Campaign 2026 recommendations for goals of care discussions, advanced directives, time-limited trials, palliative care, ICU transition programs, handoff processes, medication reconciliation, discharge planning, patient and family education, post-critical illness follow-up, physical rehabilitation, mental health support, and cognitive recovery in adult sepsis and septic shock.
Surviving Sepsis Campaign 2026 pediatric recommendations for immune stimulants in immunoparalysis, immunosuppressive therapy for hyperferritinemia, early rehabilitation bundles, targeted posthospital follow-up, post-sepsis morbidity screening, stress ulcer prophylaxis, VTE prophylaxis, nutrition, and blood products in children with sepsis.
Surviving Sepsis Campaign 2026 recommendations for blood pressure monitoring, fluid type selection, balanced crystalloids, albumin, liberal vs restrictive fluid strategies, dynamic measures for fluid responsiveness, cardiac output monitoring, serial lactate, capillary refill time, vasopressor hierarchy, inotropes, methylene blue, midodrine, and beta-blockers in adult sepsis and septic shock.
Interactive educational series for clinicians — explore the mathematics, physics, and decision science behind clinical procedures through hands-on simulations and visualizations.
Evidence-based guideline for venous thromboembolism prevention in critically ill patients, including pharmacologic and mechanical prophylaxis, special populations, and monitoring.
Evidence-based guideline for VAP prevention bundles, diagnostic approaches, empiric and targeted antimicrobial therapy, and surveillance in mechanically ventilated patients.
Evidence-based guideline for classification, imaging decisions, ICP management, surgical indications, and outcome prediction in traumatic brain injury across all severity levels.
Evidence-based guideline for systematic trauma evaluation including ABCDE primary survey, hemorrhagic shock management, damage control resuscitation, injury-specific assessment, and special populations.
Evidence-based guideline for red cell, platelet, plasma, and cryoprecipitate transfusion, massive transfusion protocols, transfusion reactions, and patient blood management in the critically ill.
Evidence-based guideline for recognition, decontamination, specific antidote therapy, and enhanced elimination in acute poisoning and overdose presentations.
Evidence-based guideline for screening, resuscitation, hemodynamic management, antimicrobial therapy, and organ support in sepsis and septic shock, synthesized from international critical care recommendations.
Evidence-based guideline for pain assessment, sedation management, delirium prevention and treatment, early mobility, and sleep promotion in the ICU — the PADIS/ABCDEF bundle approach.
Evidence-based guideline for post-ROSC management, targeted temperature management, neuroprognostication, seizure management, and long-term recovery after cardiac arrest.
Evidence-based guideline for pediatric resuscitation, respiratory emergencies, sepsis, febrile infant evaluation, seizures, dehydration, and common surgical emergencies in children.
Evidence-based guideline for nutritional assessment, enteral and parenteral nutrition, micronutrient supplementation, and special population management in the critically ill patient.
Evidence-based guideline for lung-protective ventilation, prone positioning, PEEP optimization, rescue therapies, and ventilator liberation in acute respiratory distress syndrome.
Evidence-based clinical guidelines for infection prevention practice — guideline development methodology, CLABSI prevention, and infection control standards.
Comprehensive, evidence-based clinical guidelines for intensive care practice — synthesized from multiple professional society recommendations covering sepsis, ventilation, sedation, infection prevention, nutrition, hemostasis, renal support, post-arrest care, and transfusion medicine.
Comprehensive, evidence-based clinical guidelines for emergency medicine practice — cardiac emergencies, stroke, trauma, toxicology, airway management, pediatrics, and procedural care.
Comprehensive, evidence-based clinical guidelines for emergency medicine practice — synthesized from multiple professional society recommendations covering cardiac emergencies, stroke, trauma, toxicology, airway management, pediatrics, and procedural care.
Evidence-based guideline for CLABSI prevention, including insertion and maintenance bundles, supplemental strategies, diagnosis and management of catheter-related bloodstream infections, and surveillance.
Evidence-based guideline for recognition, evaluation, thrombolysis, thrombectomy, and management of ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage in the emergency department.
Evidence-based guideline for multimodal analgesia, opioid stewardship, ultrasound-guided regional anesthesia, and procedural sedation agents and protocols in the ED.
Evidence-based guideline for AKI staging, prevention, conservative management, renal replacement therapy modalities, CRRT prescription, and special populations in the critically ill.
Evidence-based guideline for evaluation and management of surgical and non-surgical abdominal emergencies including appendicitis, cholecystitis, pancreatitis, bowel obstruction, and mesenteric ischemia.
Sepsis management in immunocompromised patients, elderly, and pregnancy; bundle compliance and quality metrics; post-sepsis syndrome; long-term outcomes and performance improvement.
PADIS management in special populations including post-operative, neurological injury, substance withdrawal (alcohol/CIWA, opioid/COWS), ECMO and CRRT dosing adjustments, plus quality metrics, bundle compliance measurement, and implementation strategies.
Extracorporeal CPR indications and evidence, CPR quality metrics and physiologic targets, pediatric cardiac arrest differences with weight-based dosing, neonatal resuscitation overview, termination of resuscitation criteria, and post-arrest care cross-reference.
VTE prophylaxis in traumatic brain injury, spinal cord injury, neurosurgery, burns, stroke, cardiac surgery, orthopedic trauma, ECMO, thrombocytopenia, active bleeding, pregnancy, and obesity; HIT recognition and alternative anticoagulants; quality metrics and compliance monitoring.
Pathogen-directed therapy for MRSA, Pseudomonas aeruginosa, Acinetobacter baumannii, ESBL-producing Enterobacterales, and Stenotrophomonas maltophilia with dosing tables, VAE versus traditional VAP surveillance reporting, NHSN definitions and algorithms, quality metrics including VAE rates and bundle compliance, and antibiotic stewardship considerations.
Recognition and management of all transfusion reactions (hemolytic, FNHTR, allergic, TRALI, TACO), TRALI vs TACO differential table, reporting requirements, patient blood management (PBM), special populations including Jehovah's Witness patients, and quality metrics.
Complete management of methanol and ethylene glycol poisoning (fomepizole, hemodialysis), carbon monoxide, cyanide, organophosphates and nerve agents, iron poisoning, caustic ingestions, local anesthetic systemic toxicity (LAST), sympathomimetic toxicity, and enhanced elimination techniques including urinary alkalinization and EXTRIP hemodialysis indications.
Continuous EEG monitoring, seizure and status epilepticus treatment, organ donation considerations, cardiac rehabilitation, ICD evaluation, cognitive recovery, and quality metrics after cardiac arrest.
Febrile seizure evaluation, status epilepticus protocol with stepwise treatment, clinical dehydration assessment, WHO dehydration classification, ORT protocol, IV fluid calculation with Holliday-Segar rule, hyponatremia correction, and pediatric diabetic ketoacidosis management including 2-bag system and cerebral edema monitoring.
Safety screening criteria for ICU mobilization, progressive mobility levels, ICU-acquired weakness diagnosis and prevention, barriers to early mobility, sleep disruption assessment and causes, non-pharmacologic and pharmacologic sleep interventions, and circadian rhythm management.
Comprehensive guide to immunonutrition (arginine, glutamine, omega-3 fatty acids, antioxidants), and nutrition management in special ICU populations including sepsis, burns, trauma, TBI, acute pancreatitis, ECMO, obesity, chronic critical illness, open abdomen, and CRRT.
Early invasive vs conservative strategy, timing of angiography, antiplatelet and anticoagulation for NSTEMI, special populations (women, elderly, diabetes, CKD, cocaine), arrhythmias, and chest pain disposition.
Scenario-specific airway management for trauma, elevated ICP, status asthmaticus, morbid obesity, pregnancy, pediatric patients, angioedema/anaphylaxis, and burns. Complete post-intubation ventilator settings, sedation/analgesia regimens, extubation criteria, and equipment reference tables by age and weight.
Comprehensive guide to perforated peptic ulcer with Boey score, mesenteric ischemia types and management, ruptured AAA emergency management, ectopic pregnancy evaluation and treatment, and special populations including pediatric, elderly, immunocompromised, and pregnant patients.
Evidence for intermittent pneumatic compression and graduated compression stockings, IVC filter indications and complications, screening ultrasound protocols, CTPA decision-making, and transition from prophylaxis to treatment.
Massive transfusion protocol activation, fixed-ratio transfusion (1:1:1 per PROPPR), TEG/ROTEM viscoelastic testing and interpretation, damage control resuscitation, TXA (CRASH-2), calcium replacement, permissive hypotension, and hemorrhage management in trauma, obstetric, and GI bleeding.
Timing of antibiotics, empiric broad-spectrum regimens by suspected source, de-escalation, duration of therapy, procalcitonin-guided discontinuation, antifungal considerations, and source control procedures.
Antimicrobial-impregnated catheters, antimicrobial lock therapy, CHG-impregnated dressings, antibiotic ointments, diagnosis of CRBSI (paired blood cultures, differential time to positivity, catheter tip culture), empiric therapy, catheter removal vs salvage, duration of therapy by organism, and suppurative thrombophlebitis.
Recruitment maneuvers and evidence from the ART trial, conservative fluid management from the FACTT trial, inhaled pulmonary vasodilators, ECMO indications and referral criteria from the EOLIA trial, high-frequency oscillatory ventilation, and corticosteroids in ARDS.
Comprehensive guide to parenteral nutrition in the ICU: indications, timing controversies, composition, lipid emulsions, monitoring, complications, transition to EN, and micronutrient supplementation including thiamine, vitamin C, vitamin D, selenium, zinc, and refeeding syndrome prevention.
Fluid management, hyperkalemia emergency algorithm, electrolyte and acid-base management, diuretic therapy including furosemide stress test, drug dosing in AKI, and nutritional considerations.
Systems of care, primary PCI, fibrinolytic therapy with dosing, pharmacoinvasive strategy, dual antiplatelet therapy, anticoagulation, adjunctive therapy, cardiogenic shock, and mechanical complications.
Failed first attempt optimization, video laryngoscopy types and evidence, bougie technique, supraglottic airways with sizing tables, intubating through SGA, front-of-neck access (FONA), surgical cricothyrotomy (scalpel-bougie-tube), needle cricothyrotomy, and the complete difficult airway algorithm.
Comprehensive guide to adhesive small bowel obstruction with CT findings, conservative management, water-soluble contrast challenge, and surgical indications; large bowel obstruction including volvulus and Ogilvie syndrome; and diverticulitis with Hinchey classification, DIABOLO trial evidence, and surgical decision-making.
Complete dosing tables for LMWH, UFH, and fondaparinux in ICU patients, renal and obesity dose adjustments, anti-Xa monitoring, key trial evidence (PROTECT, PREVENT, INSPIRATION), and duration of prophylaxis.
Comprehensive evidence review of VAP prevention bundle components including head-of-bed elevation, sedation management, oral care and chlorhexidine controversy, subglottic secretion drainage, ETT cuff pressure, suctioning, circuit management, early mobility, stress ulcer prophylaxis, and supplemental strategies including SDD/SOD, silver-coated ETTs, and probiotics.
Extended FAST technique, chest and pelvis radiography, Foley and NG tube placement, complete head-to-toe secondary survey, AMPLE history, and hemorrhagic shock classification with Classes I-IV.
Evidence-based indications, thresholds, and dosing for platelet, plasma (FFP/FP24), and cryoprecipitate/fibrinogen concentrate transfusion, including platelet refractoriness, warfarin reversal, and special considerations for HIT, TTP, ITP, and DIC.
Complete TTM protocol including historical evolution, landmark trial evidence, temperature targets, cooling methods, shivering management, complications, and special populations.
Croup scoring and management, bronchiolitis evaluation and supportive care, acute asthma severity classification and stepwise treatment, anaphylaxis recognition and epinephrine dosing, and foreign body aspiration management.
Indications, protocols, and evidence for prone positioning in ARDS based on the PROSEVA trial, procedural checklists and contraindications, neuromuscular blockade evidence from ACURASYS and ROSE trials, train-of-four monitoring, and current recommendations.
Comprehensive guide to enteral nutrition in the critically ill: timing of initiation, gastric vs post-pyloric access, advancement protocols, formula selection, gastric residual volume management, prokinetic agents, complications including aspiration and refeeding syndrome, and EN during prone positioning and vasopressor therapy.
Pre-renal, intrinsic, and post-renal AKI causes; diagnostic workup including urinalysis, FENa, FEUrea, and imaging; prevention strategies; nephrotoxin avoidance; contrast-associated AKI evidence; drug dose adjustment table.
Complete RSI protocol including preparation, pretreatment agents, induction agents with dosing tables, neuromuscular blocking agents with contraindications and reversal, paralysis verification, post-intubation sedation, confirmation of intubation, awake intubation, and drug-assisted intubation without paralysis.
Comprehensive guide to acute cholecystitis with Tokyo Guidelines severity grading, cholangitis management, ERCP indications, and acute pancreatitis with Revised Atlanta Classification, BISAP score, Ranson criteria, CTSI/Balthazar score, fluid resuscitation, nutrition, and necrotizing pancreatitis management.
Incidence and pathophysiology of VTE in critically ill patients, comprehensive ICU risk factors, and complete risk assessment scoring systems including Padua Prediction Score, Caprini Score, and IMPROVE Score.
Clinical and surveillance definitions of VAP, the VAE tier system (VAC, IVAC, PVAP), HAP versus VAP distinction, epidemiology including incidence and mortality data, pathogenesis of aspiration and biofilm formation, and modifiable and non-modifiable risk factors.
GCS scoring, TBI severity classification, Canadian CT Head Rule, New Orleans Criteria, PECARN pediatric head CT algorithm, and comparison of imaging decision rules with sensitivity and specificity data.
Two-tier trauma team activation criteria, CDC field triage, and complete ABCDE primary survey including airway with C-spine protection, breathing and ventilation, circulation with hemorrhage control, disability assessment with GCS, and exposure/environment.
Initial approach to the poisoned patient including toxidrome recognition, diagnostic workup, toxicology screen interpretation, and gastrointestinal decontamination strategies including activated charcoal, whole bowel irrigation, gastric lavage, and multi-dose activated charcoal.
Sepsis-3 definitions, SOFA and qSOFA scoring, septic shock criteria, comparison with SIRS/Sepsis-2, and screening tools (NEWS, MEWS, qSOFA, SIRS) with sensitivity and specificity data.
Pathophysiology of post-cardiac arrest syndrome, airway and ventilation targets, hemodynamic optimization, coronary angiography indications, and initial workup after ROSC.
The ABCDEF bundle framework for ICU liberation, comprehensive pain assessment tools (BPS, CPOT, NRS) with complete scoring tables, and evidence-based analgesic management including opioid dosing, non-opioid adjuncts, and multimodal protocols.
Comprehensive guide to nutrition screening tools (NUTRIC score, NRS-2002, mNUTRIC), limitations of traditional biomarkers, body composition assessment, indirect calorimetry, predictive equations, caloric and protein targets, and obesity adjustments in the critically ill adult.
Pain assessment scales (NRS, VAS, FACES, FLACC, PAINAD), oligoanalgesia prevention, and first-line non-opioid analgesics including acetaminophen, NSAIDs, subdissociative ketamine, IV lidocaine, trigger point injections, and nitrous oxide.
KDIGO AKI definition and staging criteria, RIFLE and AKIN historical comparison, novel biomarkers (NGAL, KIM-1, NephroCheck), subclinical AKI, ICU epidemiology, and outcomes by stage.
ACS spectrum definitions, Fourth Universal Definition of MI (Types 1-5), pathophysiology, initial ED evaluation, 12-lead ECG interpretation, STEMI criteria by territory, STEMI equivalents, and right ventricular MI.
Structured approach to acute abdominal pain evaluation including history, physical exam, differential diagnosis by pain location, laboratory and imaging strategy, and comprehensive appendicitis management with Alvarado score, AIR score, and CODA trial evidence.
Evidence-based guideline for the safe handling, preparation, administration, and disposal of hazardous drugs in healthcare settings, including engineering controls, PPE, and exposure management.
Evidence-based guideline for prevention, assessment, and management of oral and GI mucositis in cancer patients receiving chemotherapy, radiation, and stem cell transplantation.
Evidence-based guideline for surveillance, late effects monitoring, health promotion, and comprehensive survivorship care planning for cancer survivors.
Comprehensive, evidence-based clinical guidelines for oncology practice — synthesized from multiple professional society recommendations covering vascular access, supportive care, safety, pain management, immunotherapy, and survivorship.
Comprehensive, evidence-based clinical guidelines for oncology practice — vascular access, supportive care, safety, pain management, immunotherapy, and survivorship.
Evidence-based guideline for recognition, grading, and management of immune-related adverse events (irAEs) across all organ systems in patients receiving checkpoint inhibitor immunotherapy.
Evidence-based guideline for prevention, recognition, and management of chemotherapy extravasation injuries, including agent classification, antidote protocols, and follow-up care.
Evidence-based guideline for selection, insertion, maintenance, and complication management of central venous access devices in oncology patients, synthesized from multiple professional society recommendations.
Evidence-based guideline for risk assessment, prophylaxis, diagnosis, and treatment of venous thromboembolism in cancer patients, including catheter-related thrombosis.
Pediatric oncology, elderly patients, thrombocytopenic and anticoagulated patients, device removal criteria and procedures, patient and caregiver education, and quality surveillance for CVADs in oncology.
Risk-stratified survivorship care models, shared care integration, transition from oncology to primary care, pediatric and AYA survivorship, childhood cancer late effects, financial toxicity, and psychosocial support resources.
Medical surveillance program design and components, biological monitoring, reproductive health counseling and alternative duty policies, training and competency assessment requirements, documentation and record-keeping, non-antineoplastic hazardous drug considerations, home administration guidance, and quality assurance.
Depression, anxiety, PTSD, fear of recurrence, sexual health, physical activity, nutrition, smoking cessation, alcohol, sun protection, and immunizations for cancer survivors.
Empiric and targeted antifungal therapy for invasive aspergillosis and candidemia, central line-associated bloodstream infections in neutropenic patients, infection prevention measures, and patient and caregiver education.
Patient assessment and grading tools for CINV including CTCAE and MASCC Antiemesis Tool, evidence-based non-pharmacological interventions, guideline implementation strategies, quality improvement metrics, and patient education.
Management of cancer-associated VTE in special populations including brain tumors, thrombocytopenia, renal impairment, GI/GU cancers, recurrent VTE on anticoagulation, incidental and subsegmental PE, and IVC filter indications.
Adjuvant analgesic dosing for neuropathic and bone pain, interventional pain procedures, palliative radiation, and chemotherapy-induced peripheral neuropathy prevention and treatment.
Spill classification and step-by-step response procedures, spill kit contents, personnel exposure management during spills, hazardous drug waste segregation and disposal, and surface decontamination protocols including deactivation, decontamination, and cleaning agents.
Flushing and locking protocols, dressing change procedures, needleless connector management, port access and deaccess procedures, blood sampling, and patency assessment for CVADs in oncology patients.
Grade-based management of immune-mediated endocrine toxicities (thyroid disorders, adrenal insufficiency, hypophysitis, type 1 diabetes) and pneumonitis including workup, corticosteroid protocols, hormone replacement, and immunosuppressive escalation.
Fluoroquinolone prophylaxis, antifungal prophylaxis, antiviral and PJP prophylaxis, G-CSF primary and secondary prophylaxis with dosing and timing, therapeutic G-CSF in established febrile neutropenia, and management of persistent fever and documented infections.
Guideline-recommended antiemetic regimens by emetogenic risk level, multi-day chemotherapy protocols, oral chemotherapy CINV, radiation-induced nausea and vomiting, breakthrough and refractory CINV management, and considerations for pediatric, geriatric, and organ-impaired populations.
Complete treatment protocols for cancer-associated VTE including LMWH dosing, DOAC regimens (rivaroxaban, edoxaban, apixaban), warfarin considerations, duration of anticoagulation, and landmark trial data from SELECT-D, HOKUSAI-VTE Cancer, ADAM-VTE, and CARAVAGGIO.
Complete opioid pharmacotherapy for cancer pain including equianalgesic dosing, titration protocols, opioid rotation, breakthrough pain management, methadone pharmacology, and side effect treatment.
Complete PPE specifications for hazardous drug handling by activity type, including glove, gown, eye/face, and respiratory protection requirements; detailed procedures for receiving, storage, compounding, administration, patient care, and transport.
Insertion site selection, ultrasound-guided placement, tip confirmation, skin antisepsis, dressing and securement, and site care protocols for central venous access devices in oncology patients.
Anthracycline cardiomyopathy, radiation-associated cardiovascular disease, cardiac monitoring protocols, cardioprotective strategies, and screening for secondary malignancies in cancer survivors.
Empiric intravenous antibiotic monotherapy and combination regimens with complete dosing, indications for vancomycin and anti-gram-positive agents, antibiotic de-escalation and duration criteria, outpatient eligibility for low-risk febrile neutropenia, oral antibiotic regimens, and monitoring requirements.
Comprehensive review of antiemetic drug classes used in CINV prophylaxis and treatment: NK1 receptor antagonists, 5-HT3 receptor antagonists, corticosteroids, olanzapine, dopamine antagonists, benzodiazepines, and cannabinoids with complete dosing, pharmacokinetics, and adverse effect profiles.
Signs and symptoms of extravasation (early and late), differential diagnosis, step-by-step immediate management algorithm, specific antidote protocols with complete dosing for dexrazoxane, hyaluronidase, sodium thiosulfate, and DMSO, and thermal management by agent class.
Evidence-based recommendations for VTE prophylaxis in ambulatory, hospitalized, and surgical cancer patients, including CVAD-related thrombosis prevention, with complete dosing tables and key trial data.
Hazardous drug definitions, NIOSH classification criteria, national drug list organization, exposure routes and health effects, facility risk assessment, and complete engineering control specifications including BSCs, CACIs, CSTDs, and ventilation requirements.
CVAD types and oncology-specific indications, patient assessment framework, vein selection in cancer patients, device selection algorithms, and special population considerations for central venous access in oncology.
Survivorship care plan components, structure, and evidence-based surveillance schedules for recurrence monitoring in breast, colorectal, prostate, lung, lymphoma, and head and neck cancer survivors.
Classes of immune checkpoint inhibitors, mechanism and epidemiology of irAEs, CTCAE grading, general management framework, corticosteroid protocols, immunosuppressive escalation, and infusion reactions.
Complete emetogenic risk classification of intravenous and oral chemotherapy agents (high, moderate, low, minimal), types of CINV, pathophysiology of chemotherapy-induced emesis, and patient- and treatment-related risk factors.
Pathophysiology of cancer-associated thrombosis, Virchow's triad in malignancy, and validated VTE risk assessment models including the Khorana score, Vienna CATS score, PROTECHT score, and ONKOTEV score with complete scoring tables.
Comprehensive pain assessment tools, classification systems, and cancer-specific pain syndromes for systematic evaluation of pain in oncology patients.
What is vascular access? Definitions, clinical context, the full VAD spectrum from peripheral to central, indications for each device type, and who performs vascular access procedures.
The definitive clinical reference on vascular access — device spectrum, evidence-based selection, current clinical standards, complication overview, documentation, and quality metrics for clinicians.
Complete guide to building, measuring, and governing a vascular access team (VAT) program: models, evidence, ROI calculation, quality metrics, scope of practice, and program governance.
Annual state-of-the-practice safety report for vascular access: national CLABSI rates, PICC complication data, peripheral IV failure rates, phlebitis benchmarks, catheter-related DVT epidemiology, and the current evidence base driving vascular access safety standards.
Comprehensive guide to vascular access quality metrics: CLABSI rates and SIR benchmarking, first-attempt success rates, phlebitis rates, catheter utilization ratios, PICC appropriateness tracking, dwell time management, and building a vascular access quality dashboard.
The most comprehensive vascular access knowledge base for clinicians — evidence-based guides on PICC lines, CVCs, CLABSI prevention, complications, ultrasound, credentialing, and infusion therapy.
Clinical reference for vascular access in special populations: pediatric, NICU/neonatal, oncology, hemodialysis, critical care, geriatric, obese, and immunocompromised patients — device selection, technique modifications, and population-specific risks.
Complete comparison of all vascular access device types: PIV, midline, PICC, CVC, tunneled catheter, port, hemodialysis catheter, IO, and arterial line — with a clinical selection guide.
Comprehensive vascular access device (VAD) competency and credentialing checklist covering peripheral IV, midline, PICC, central venous catheter, and implanted port access — including ultrasound guidance competency, bundle compliance verification, and annual maintenance requirements.
Complete guide to vascular access credentialing and certification: VA-BC, CRNI, PICC insertion competency, ultrasound credentialing, institutional privileging, and building a credentialing program.
Free clinical resources for vascular access professionals: safety reports, CLABSI prevention frameworks, competency checklists, and audit tools — designed for hospital educators and VAT program leaders.
Evidence-based guides, policies, guidelines, patient education, and clinical resources for vascular access practice — PICC lines, central venous catheters, CLABSI prevention, infusion therapy safety, and more.
Complete ultrasound-guided PICC insertion guide: pre-insertion vein survey, long-axis technique for basilic vein cannulation, guidewire US confirmation, catheter measurement, and intraoperative tip guidance with ECG.
Guide to ultrasound-guided peripheral IV for difficult venous access: DIVA score application, vein selection (diameter, depth), catheter length requirements, short-axis technique, common pitfalls, and when to escalate to midline or PICC.
Comprehensive guide to ultrasound technique for vascular access: probe selection, short-axis vs long-axis approach, in-plane vs out-of-plane needle guidance, dynamic vs static technique, and practical tips for needle visualization.
Framework for ultrasound credentialing in vascular access: didactic requirements, simulation, proctored case minimums, competency assessment, scope of practice definitions, and maintenance of competency requirements per AVAR.
Clinical guide to tunneled central venous catheters: Hickman, Broviac, and Groshong types, indications, care and maintenance, flushing protocols, complication management, and comparison with implanted ports.
The complete clinical reference on PICC lines: indications, ultrasound-guided insertion, CEVAD tip position standards, maintenance protocols, complications, and removal — evidence-based.
Complete step-by-step guide to ultrasound-guided PICC line insertion using the modified Seldinger technique: site selection, vein assessment, catheter measurement, sterile technique, and post-insertion verification.
Clinical indications for PICC line placement — appropriate and inappropriate criteria and MAGIC, PICC for IV antibiotics, chemotherapy, TPN, and vesicants, and absolute contraindications.
Guide to vascular access requirements for parenteral nutrition (PN): central vs peripheral PN access criteria, osmolarity thresholds, PICC vs CVC for TPN, dedicated PN lumen, filtration requirements, administration set change intervals, and DEHP-free requirements.
Comprehensive guide to oncology vascular access: port vs PICC decision-making, chemotherapy central access requirements, vesicant administration, CLABSI prevention in neutropenic patients, power-injectable port selection, and access management across the cancer treatment continuum.
Complete clinical guide to non-tunneled central venous catheters: site selection (IJ vs subclavian vs femoral), ultrasound-guided insertion, complications (pneumothorax, hemothorax, arterial injury), CLABSI prevention, and removal.
Complete NICU vascular access guide: umbilical arterial and venous catheters (UAC/UVC), neonatal PICC lines, neonatal peripheral IV, gestational age considerations, skin protection, heparin-free protocols, and light protection for neonatal PN.
Framework for building an institutional vascular access privileging program: scope of practice delineation, privilege categories, competency documentation, re-privileging, medical staff credentialing vs. nursing competency, and TJC compliance.
Complete guide to IV infiltration and extravasation: infiltration staging scale (0–4), vesicant vs. non-vesicant injury, antidote table (dexrazoxane, hyaluronidase, phentolamine), emergency response, and prevention.
Clinical guide to high-alert IV medications: ISMP list of high-alert medications in vascular access, safety protocols for concentrated KCl, heparin, insulin, opioids, neuromuscular blockers, and chemotherapy — with required safeguards.
Clinical guide to hemodialysis vascular access: AVF creation and maturation criteria, AV graft cannulation, tunneled dialysis catheter placement and complications, vessel preservation in CKD/ESRD, fistula-first policy, buttonhole vs rope-ladder technique, and catheter-to-fistula transition.
Clinical guide to hemodialysis vascular access: AV fistula (preferred), AV graft, and tunneled hemodialysis catheter — indications, care, complications, the access hierarchy, and vessel preservation for CKD patients.
Evidence-based vascular access device selection using standards, the Vessel Health and Preservation (VHP) framework, DIVA score, osmolarity thresholds, and the MAGIC appropriateness criteria.
CVAD tip location standards per CEVAD 2020 consensus: cavoatrial junction target, radiographic landmarks, device-specific tip positions, tip confirmation methods (ECG, CXR, fluoroscopy), and malposition classification.
Clinical guide to critical care vascular access: CVC site selection in the ICU, arterial line placement and management, vasopressor central access requirements, CRRT/CVVHD access, pulmonary artery catheter, CLABSI prevention in the ICU, and simultaneous multi-device management in the critically ill.
Complete overview of CLABSI definition (NHSN criteria), epidemiology (incidence, mortality, cost), CLABSI vs CRBSI distinction, NHSN surveillance methodology, SIR benchmarking, and how CLABSI rates are calculated.
Evidence-based guide to antimicrobial-impregnated catheters (CHG/SS, minocycline-rifampin), antimicrobial dressings, and antimicrobial lock therapy for CLABSI prevention in high-risk settings — indications, evidence, and limitations.
Complete guide to air embolism in vascular access: pathophysiology, prevention during insertion and removal, recognition of venous air embolism, emergency management (Durant's maneuver, aspiration, oxygen therapy), and high-risk scenarios.
Establishes standards for product evaluation, selection, inspection, problem reporting, and supply chain disruption management to ensure vascular access devices and infusion products meet the highest standards of safety, efficacy, and reliability.
Establishes standards for safe handling and disposal of regulated medical waste, sharps safety, needlestick injury prevention, use of safety-engineered devices, injury reporting, and patient and caregiver education for home infusion waste management.
Establishes standards for minimizing latex exposure, identifying at-risk patients and healthcare workers, managing allergic reactions, and ensuring latex-free care environments for latex-sensitive and latex-allergic individuals.
Establishes comprehensive standards for the safe handling, preparation, administration, and disposal of hazardous drugs across all care settings, including PPE requirements, engineering controls, environmental monitoring, spill management, and medical surveillance programs.
Establishes comprehensive standards for preventing, recognizing, and responding to controlled substance diversion in healthcare settings, including chain of custody requirements, waste management, detection methods, and recovery support for affected healthcare workers.
Establishes comprehensive standards for identifying, documenting, investigating, and learning from adverse events, serious adverse events, and near-miss incidents associated with vascular access devices and infusion therapy.
This article examines how elevated cortisol levels—the body's primary stress hormone—affect hospital staff's health and work performance. It explains that healthcare workers face unique stressors such as high-stakes patient care, excessive workloads, and lack of institutional support, which can lead to chronically elevated cortisol and subsequent health issues including anxiety, depression, cognitive impairment, and cardiovascular problems. These effects ultimately reduce work efficiency and can compromise patient safety. The article reviews research on cortisol patterns in emergency care providers, discusses how the COVID-19 pandemic exacerbated these challenges, and offers strategies for managing cortisol levels through lifestyle modifications (exercise, sleep hygiene), stress management techniques (mindfulness, CBT), organizational changes (workload management, flexibility), and when necessary, medical interventions. It concludes by urging healthcare organizations to prioritize staff well-being through transparent, supportive management practices to maintain both employee health and quality patient care.
This comprehensive guide outlines evidence-based principles of vascular access and infusion therapy across the lifespan, including neonatal, pediatric, obstetric, and geriatric populations. It covers regulatory compliance, ethical practice, device selection, infusion accuracy, and population-specific risks such as DEHP exposure, DIVA management, pregnancy-related hypercoagulability, and geriatric polypharmacy. Designed for clinicians, nurses, and vascular access specialists, this resource supports safe, patient-centered decision-making aligned with current standards of care.
Defines the organizational requirements for the assessment, establishment, governance, financial management, and continuous improvement of a dedicated vascular access specialist service, including leadership structure, team nomenclature, budgetary processes, and interprofessional safety integration.
Establishes the organizational model for vascular access service delivery, defining the core service components, operational coverage requirements, consultative approach, and technology integration necessary for a comprehensive, holistic infusion therapy program across inpatient and outpatient settings.
Defines the regulatory hierarchy governing clinician scope of practice, establishes the framework for practice expansion and delegation of vascular access tasks, and delineates the professional roles and responsibilities of all personnel involved in infusion therapy.
Establishes the organizational framework for continuous quality improvement in vascular access services, including the adoption of validated QI methodologies, audit and feedback mechanisms, adverse event surveillance, medication safety integration, and the maintenance of a Just Culture environment.
Mandates comprehensive, health-literacy-appropriate patient and caregiver education for all vascular access and infusion therapy encounters, defines the required educational content, and establishes the teach-back and return demonstration standards for verification of learning.
Mandates the integration of vascular access expertise into cross-disciplinary institutional safety programs and establishes the standards for safe care transitions involving patients with indwelling vascular access devices across acute, community, home, and long-term care settings.
Establishes the legal, ethical, and procedural requirements for obtaining, documenting, and maintaining informed consent for vascular access procedures, including the components of the consent discussion, requirements for emergency situations, and provisions for patients who lack decision-making capacity.
Establishes the foundational principles governing the administration of infusion therapy and the management of vascular access devices across all specialized patient populations, including pediatric, neonatal, obstetric, and geriatric cohorts.
Mandates that all vascular access device selection, antiseptic agent selection, and infusion technology decisions be rooted in demonstrated clinical evidence and patient outcomes, and establishes the systematic clinical monitoring requirements for all vascular access devices.
Establishes the organizational commitment to evidence-based practice in vascular access, mandates the continuous revision of policies based on current research, defines the implementation science framework for translating evidence into bedside practice, and outlines the infrastructure requirements for supporting clinician-researchers.
Establishes the standards, requirements, and minimum data elements for clinical documentation of all vascular access events—from insertion through removal—in the electronic health record, including insertion documentation, ongoing assessment, medication administration, and the integration of EHR clinical decision support tools.
Establishes the standards, framework, and requirements for initial and ongoing competency assessment and validation for all clinicians performing vascular access and infusion therapy procedures, including educational delivery methods, simulation requirements, insertion training protocols, and program evaluation metrics.
Association for Vascular Access (AVA) Adult Clinical Practice Guidelines — JAVA January Supplement 2026, Volume 31. Evidence-based recommendations for vascular access practice.
Association for Vascular Access Adult Clinical Practice Guidelines (JAVA 2026, Vol. 31) — Part 5: Comprehensive glossary of vascular access terminology and definitions referenced throughout the guidelines.
Association for Vascular Access Adult Clinical Practice Guidelines (JAVA 2026, Vol. 31) — Part 4 covering Sections 5–6: Device Maintenance, Complication Identification & Management, and Special Patient Populations.
Association for Vascular Access Adult Clinical Practice Guidelines (JAVA 2026, Vol. 31) — Part 3 covering Sections 3–4: Vascular Access Device Selection, Site Selection, and Insertion Techniques including ultrasound guidance.
Association for Vascular Access Adult Clinical Practice Guidelines (JAVA 2026, Vol. 31) — Part 2 continuing Section 1 on implementation considerations, barriers, products, bundles, and checklists for vascular access infrastructure.
Clinical guidelines as static PDFs are failing healthcare. Learn why API-first medical knowledge distribution is essential for modern clinical decision support and how open-source approaches can revolutionize healthcare interoperability.
Establishes standards for the safe insertion of all vascular access devices, including peripheral intravenous catheters, central venous access devices, and arterial catheters, with requirements for aseptic technique, ultrasound guidance, and complication management.
Establishes supplementary infection prevention standards beyond standard precautions for patients with known or suspected communicable disease, including contact, droplet, and airborne precaution requirements, enhanced barrier precautions in long-term care, and crisis standards for pandemic response.
Why IntracavOS moved from cloud APIs to a fully isolated, self-hosted AI system: exploring the security philosophy behind closed-loop healthcare AI and the paranoid approach to patient data protection.
A candid critique of healthcare's resistance to innovation: why vascular access and clinical practice remain stuck in outdated patterns while real problems like CLABSIs persist.
Why we built IntracavOS on NixOS: A reproducible, secure, and scalable operating system designed specifically for healthcare AI deployment. Learn about our architecture and why traditional approaches fail.
Comprehensive guide to preventing hemolysis during blood draws: understanding catheter-to-vein ratio (CVR), cavitation physics, and evidence-based techniques for optimal lab sample quality.
Establishes requirements for skin antisepsis and site preparation prior to vascular access device insertion, including antiseptic selection, application technique, and neonatal-specific precautions.
Evidence-based guidelines for the prevention, assessment, and management of catheter-associated skin injury (CASI) and medical adhesive-related skin injury (MARSI) in patients with peripheral and central vascular access devices, including risk assessment, dressing selection, atraumatic removal techniques, and management of established injury.
A comprehensive methodology handbook for developing clinical guidelines, expert guidance documents, consensus statements, and practice statements in infection prevention and healthcare epidemiology. Covers proposal processes, systematic literature review, evidence grading, consensus methods, and development timelines.
Development checklists (32-month, 22-month, and 6-month timelines), review and comment period procedures, writing panel author responsibilities, inclusive language guide, and acronyms for infection prevention guideline development.
Evidence-based standards for subcutaneous infusion therapy including hypodermoclysis, subcutaneous medication administration, continuous subcutaneous insulin infusion, and on-body delivery systems across acute care, ambulatory, and home care settings.
Establishes standards for post-insertion care of all vascular access devices, including systematic assessment protocols, dressing selection and change intervals, skin antisepsis, site protection, infection prevention strategies, documentation requirements, and population-specific considerations.
Evidence-based guidelines for the assessment, prevention, and management of central vascular access device malposition, including primary and secondary malposition types, prevention through insertion technique, diagnostic evaluation, and management approaches including noninvasive and invasive repositioning.
Establishes requirements for evidence-based pain assessment and management during vascular access procedures across all patient populations, from neonates through adults.
Evidence-based standards for the safe insertion, management, medication administration, and complication prevention of neuraxial access devices including epidural and intrathecal catheters, implanted neuraxial ports, and intrathecal drug delivery (ITDD) systems across acute care, outpatient, and home care settings.
Critical analysis of cortisol dysregulation in hospital staff and its impact on clinical performance, patient safety, and healthcare workforce wellbeing with evidence-based interventions.
Evidence-based standards for preventing air embolism during vascular access procedures, including CVAD removal protocols, recognition of signs and symptoms, and emergency response for suspected venous or arterial air embolism.
Establishes requirements for the appropriate selection, use, configuration, labeling, and replacement of primary and secondary administration sets for all infusion types, including standard solutions, parenteral nutrition, lipids, blood products, propofol, and hemodynamic monitoring systems.
Establishes standards for the application of Aseptic Non Touch Technique (ANTT®) across all invasive clinical procedures and vascular access device management, including risk assessment framework, aseptic field management, competency requirements, and environmental management.
Clinical guideline for safe and effective therapeutic phlebotomy practice, including vascular access device selection, treatment parameter establishment, adverse effect prevention and management, psychosocial considerations, patient education, and combination therapy for conditions such as polycythemia vera and hereditary hemochromatosis.
Complete guide to maximizing Lumen effectiveness: best practices for prompting, query formulation, and leveraging AI assistance for vascular access clinical practice and research.
Comprehensive guide to clinical decision-making in vascular access: exploring interprofessional collaboration, evidence-based protocols, and patient-centered care strategies for optimal outcomes.
Evidence-based clinical guidelines for vascular access device removal: comprehensive protocols for PIVCs, midline catheters, and central lines to optimize patient safety and outcomes.
Comprehensive clinical guideline for Peripheral Arterial Disease (PAD) management in vascular access: evidence-based protocols for assessment, prevention, and treatment strategies.
Evidence-based standards for preventing catheter damage, recognizing signs of compromise including pinch-off syndrome, and managing catheter damage through repair, exchange, or removal with post-procedure monitoring requirements.
Establishes comprehensive standards for hand hygiene practice across all care settings, including indications, approved techniques, product selection, fingernail and jewelry standards, and organizational compliance strategies to prevent healthcare-associated infections.
Establishes requirements for the selection, use, configuration, disinfection, and replacement of add-on devices in vascular access infusion systems, including extension sets, manifolds, stopcocks, filters, and closed system transfer devices.
Clinical practice guideline establishing standards for safe and effective implementation of patient-controlled analgesia across healthcare settings, including pharmacologic agents, routes of administration, monitoring requirements, and authorized agent-controlled analgesia protocols.
Establishes standards for protecting vascular access device insertion sites from dislodgement, patient manipulation, and environmental contamination, including joint stabilization practices and the judicious and restrained use of physical immobilization methods.
Evidence-based standards for identifying risk factors for catheter-associated thrombosis, preventing thrombotic complications through device selection and insertion technique, monitoring and diagnosing DVT, and managing confirmed thrombosis including anticoagulation therapy across diverse patient populations.
Establishes standards for flow-control device selection and use in infusion therapy, including electronic infusion pumps, smart pump dose error reduction systems, non-electronic devices, alarm management, and organizational standardization requirements.
Establishes standards for the access, maintenance, dressing, and patient education requirements for implanted vascular access ports, including noncoring needle selection, flushing protocols, power injection verification, and ongoing device surveillance.
Establishes requirements for in-line filtration of parenteral solutions, including mandatory filters for parenteral nutrition and intraspinal infusions, filter selection principles, population-specific indications, change intervals, safety precautions, and prohibited practices.
Evidence-based standards for safe compounding and preparation of parenteral solutions and medications, covering sterile technique, pharmacy-based preparation, vial and ampoule handling, labeling requirements, and competency requirements for all clinicians involved in medication preparation.
Evidence-based standards for safe preparation, handling, and administration of antineoplastic medications including prescribing authorization, occupational safety and PPE requirements, closed system drug transfer devices, spill management, vesicant administration, and adverse reaction protocols.
Standards for preventing, assessing, and managing vascular access device occlusion, including thrombotic and chemical causes, thrombolytic therapy, and catheter clearance agents.
Establishes standards and requirements for flushing and locking all vascular access devices to maintain catheter patency, prevent occlusion, reduce catheter-associated bloodstream infection risk, and ensure safe medication delivery across all device types and patient populations.
Evidence-based standards for preventing, recognizing, and managing bloodstream infections associated with peripheral and central vascular access devices, including care bundles, diagnostic criteria, and device removal decisions.
Evidence-based standards for the clinical evaluation, insertion, management, complication monitoring, and removal of intraosseous vascular access devices across emergent and non-emergent clinical applications in adult and pediatric patients.
Establishes standards for the warming of blood products, intravenous fluids, and contrast media, including device requirements, temperature limits, prohibited methods, monitoring obligations, and quality assurance for all patient populations including neonates.
Establishes requirements for the securement of all vascular access devices to prevent complications associated with dislodgement and movement at the insertion site, including acceptable securement methods, device-specific guidance, and assessment standards.
Establishes baseline infection prevention standards applicable to all patient care activities regardless of diagnosis, including personal protective equipment selection and use, respiratory hygiene, equipment cleaning and disinfection, and care practices across transitional settings.
Establishes standards for hemodialysis vascular access device selection, vessel health and preservation, access hierarchy, infection prevention, hub care, AVF/AVG cannulation, catheter locking solutions, and patient education for patients receiving or anticipated to receive hemodialysis.
Establishes standards for the selection and application of vascular visualization technology—including ultrasound, near-infrared, and visible light devices—to improve vascular access insertion success and reduce complications across all patient populations.
Establishes requirements for selection, disinfection, flushing and clamping sequences, replacement intervals, and infection prevention practices for all needleless connectors used on peripheral and central vascular access devices.
Standards of practice for the prevention, recognition, and management of infiltration and extravasation from peripheral and central vascular access devices, including antidote protocols.
Establishes evidence-based criteria for the selection and planning of vascular access devices across all device types and patient populations, from short peripheral catheters through central venous access devices and arterial catheters.
Evidence-based standards for the classification, prevention, assessment, and management of phlebitis associated with peripheral and central vascular access devices.
Establishes standards for central vascular access device tip location confirmation, including acceptable tip positions, real-time tip location methods, re-evaluation protocols, transfer criteria, and documentation requirements for all patient populations.
policiesClinicianVascular Access
ESC
Type to search policies, guidelines, and blog posts